Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and effect of LEO 90100 aerosol foam on HPA axis and calcium metabolism in adolescents with plaque psoriasis
2015-000839-33Phase 2Completed
- Sponsor
- LEO Pharma
- Start
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of calcipotriol + betamethasone in plaque psoriasis, sponsored by LEO Pharma. Primary endpoint: Adverse events. Started Nov 2015; status: completed.
02
Drugs
calcipotriol + betamethasone
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on 2015-000839-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000839-33.